Current Treatment Approaches to HCC with a Special Consideration to Transplantation
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The mainstay of treatment of HCC has been both resectional and transplantation surgery. It is well known that, in selected, optimized patients, hepatectomy for HCC may be an option, even in patients with underlying...
Saved in:
Main Authors: | N. Bhardwaj, M. T. P. R. Perera, M. A. Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2016/7926264 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation
by: Juliet A. Emamaullee, et al.
Published: (2019-01-01) -
Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
by: Yulong Wei, et al.
Published: (2021-01-01) -
A patient-derived HCC spheroid system to model the tumor microenvironment and treatment response
by: Emilie Crouchet, et al.
Published: (2025-02-01) -
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
by: Meng Wu, et al.
Published: (2025-02-01) -
Pembrolizumab for the Treatment of Locally Advanced Cutaneous Squamous Cell Carcinoma: Patient Selection and Special Considerations
by: Stewart M, et al.
Published: (2025-02-01)